Accentrix injection is an intravitreal anti-VEGF treatment containing ranibizumab, used to treat several sight-threatening retinal diseases. Given directly into the eye by a retina specialist, this ranibizumab injection works by controlling the abnormal growth and leakage of blood vessels in the retina and by reducing the swelling (fluid build-up) that damages central vision. For many patients with conditions like wet age-related macular degeneration or diabetic eye disease, Accentrix injection can stabilise and often improve vision when started early. This guide explains its uses, benefits, procedure, side effects, and cost.
What Is Accentrix Injection?
Accentrix injection is a doctor-prescribed intravitreal injection meaning it is delivered directly into the vitreous cavity, the gel-filled space inside the eye. It is manufactured by Novartis and contains the active drug ranibizumab. It is administered only by an eye specialist in a clinical setting and should never be self-administered.
An intravitreal injection places a high concentration of medicine exactly where it is needed at the retina while keeping the amount that reaches the rest of the body very low. This targeted delivery is what makes anti-VEGF injections like Accentrix effective for retinal disease while minimising systemic side effects. (Note: Accentrix is Novartis’s branded ranibizumab and is the same molecule sold internationally as Lucentis; it is the original drug, not a biosimilar.)
How Does Accentrix Injection Work?
Accentrix works as an anti-VEGF (vascular endothelial growth factor) agent. VEGF is a protein that, in excess, triggers the growth of fragile, abnormal blood vessels in the retina and makes them leak fluid and blood. This leakage causes the swelling and bleeding that distort and damage central vision.
The ranibizumab in Accentrix binds to VEGF and blocks its action. By switching off this signal, the injection helps prevent new abnormal vessels from forming, reduces leakage, and allows existing fluid to clear. As the retina dries out and settles, vision is stabilised and, in many cases, improved.
Conditions Treated by Accentrix Injection
Accentrix injection is commonly prescribed for retinal diseases driven by abnormal blood vessels or swelling, including:
- Wet (neovascular) age-related macular degeneration (AMD)
- Macular edema following retinal vein occlusion (RVO)
- Diabetic macular edema (DME) and diabetic retinopathy
- Retinopathy of prematurity (ROP) in some infants
In each of these conditions, timely anti-VEGF treatment helps slow disease progression and preserve central vision that might otherwise be permanently lost.
Benefits of Accentrix Injection
The main benefits of Accentrix injection include:
- Targeted treatment delivered straight to the retina, where the disease is active
- Rapid reduction of swelling and leakage, often with measurable improvement within weeks
- Potential to improve vision, not just halt decline, particularly with early treatment
- Fewer systemic side effects compared with treatments that act on the whole body
Crucially, early intervention improves long-term outcomes and can help prevent irreversible vision loss in progressive retinal diseases.
Accentrix Injection Procedure: What to Expect
The Accentrix injection procedure is a quick outpatient process, and numbing drops keep discomfort to a minimum. A typical visit involves:
- A pre-injection examination of the eye and retina
- Cleaning of the eye and application of local anaesthetic (numbing) drops
- A sterile injection of the medicine into the vitreous cavity, which takes only seconds
- A brief period of observation, followed by same-day discharge
Most patients feel only mild pressure rather than pain. Follow-up visits and retinal imaging (such as an OCT scan) are used to monitor your response and decide when the next injection is needed.
Side Effects & Risks of Accentrix Injection
Most side effects of Accentrix injection are mild and temporary, but it is important to know the warning signs of rarer, serious problems.
Mild and common: eye pain or irritation, redness, a small red patch on the white of the eye (subconjunctival haemorrhage), temporary blurred vision, floaters, and a foreign-body or gritty sensation.
Serious but rare: endophthalmitis (a serious infection inside the eye), a sustained rise in intraocular pressure, retinal detachment, and sudden changes in vision. Very rarely, anti-VEGF treatment has been associated with systemic events.
Contact your doctor immediately if you experience severe eye pain, marked loss of vision, increasing redness, or any signs of infection after the injection.
Precautions & Aftercare
Before the procedure, tell your doctor about any medical conditions, current medications, allergies, and previous eye surgeries, so they can confirm the treatment is safe for you.
After the procedure, look after the eye by:
- Not rubbing or pressing the eye
- Using any prescribed eye drops as directed
- Attending all follow-up appointments
- Temporarily avoiding swimming and eye makeup, as advised by your doctor
Cost of Accentrix Injection & Treatment Protocol
In India, the cost of an Accentrix injection typically ranges from around ₹15,000 to ₹35,000 per injection, though this is approximate and varies. The price depends on factors such as:
- The number of injections required
- The clinic or hospital and its location
- The treating doctor’s expertise
- Follow-up tests and retinal imaging
- Insurance coverage
It is worth knowing that ranibizumab biosimilars (such as Razumab) are usually available at a lower price, and your insurance may cover part of the cost so it is best to confirm the current price and treatment plan with your hospital. Most retinal conditions require more than one injection: treatment often begins with monthly “loading” doses, followed by maintenance injections based on how your eye responds.
Who Should Not Take Accentrix Injection? (Eligibility & Contraindications)
Accentrix may not be suitable for everyone. It is generally avoided in people with:
- An active eye or surrounding (periocular) infection
- Severe active inflammation inside the eye
- A recent major eye surgery (timing must be assessed)
- A known hypersensitivity (allergy) to ranibizumab
It is also used with caution in pregnancy and breastfeeding. Ultimately, only a qualified ophthalmologist can decide whether Accentrix is appropriate, based on your medical history and retinal imaging.
Is Accentrix Injection Right for You? (Success Rate & Outcomes)
Anti-VEGF therapy with ranibizumab has a strong track record: many patients experience stabilisation or improvement of vision, and a reduction in retinal swelling, especially when treatment is started early. However, results are not guaranteed and vary from person to person. Effectiveness depends on the type and severity of the retinal disease and, importantly, on consistent treatment and regular follow-up. Skipping injections or follow-ups can allow the disease to progress, so adherence is key to the best possible outcome.
Conclusion: Managing Retinal Diseases with Accentrix
Accentrix injection (ranibizumab) is a well-established anti-VEGF treatment that can protect and often improve vision in retinal diseases such as wet AMD, diabetic macular edema, and retinal vein occlusion. Its targeted, intravitreal delivery offers meaningful benefits with a generally good safety profile, though it requires ongoing treatment and monitoring. If you have been diagnosed with a retinal disease or notice any change in your central vision consult a retina specialist promptly. Proactive treatment and steady follow-up give you the best chance of preserving your sight.
